Showing results (1-10 of 359) with videos related to

Sort By:
Pageof 36
Clinical Nuclear Medicine|August 25, 2016
Nonneoplastic Neuroma After Radical Prostatectomy Is Not a Mimicker of Lymph Node Metastases on 68Ga-PSMA Ligand PET/CTThorsten Derlin, Udo Schumacher, Frank M Bengel
Current Radiopharmaceuticals|May 6, 2020
Emerging Molecular Targets for Imaging of Atherosclerotic Plaque using Positron Emission TomographyRudolf A Werner, Frank M Bengel, Thorsten Derlin
Der Radiologe|February 14, 2020
[Theranostics and hybrid imaging for somatostatin receptor-expressing tumors]Rudolf A Werner, Frank M Bengel, Thorsten Derlin
Clinical Nuclear Medicine|January 13, 2016
Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDGThorsten Derlin, Danny Jonigk, Johann Bauersachs, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2022
<sup>177</sup>Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate CancerThorsten Derlin, Liam Widjaja, Rudolf A Werner, et al.
Clinical Nuclear Medicine|February 15, 2017
Visualization of Posttraumatic Splenosis on Chemokine Receptor CXCR4-Targeted PET/CTThorsten Derlin, Hans-Jürgen Wester, Frank M Bengel, et al.
Radiologie (Heidelberg, Germany)|June 16, 2023
[Positron emission tomography in oncology]Christoph P Czerner, Thorsten Derlin, Frank M Bengel, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Vessel Wall Inflammatory Activity as Determined by F-18 Fluorodeoxyglucose PET in Large Vessel Vasculitis Is Attenuated by Immunomodulatory DrugsRomilda Sherzay, Torsten Witte, Thorsten Derlin, et al.
JACC. Cardiovascular Imaging|December 8, 2022
Parametric Imaging of Biologic Activity of Atherosclerosis Using Dynamic Whole-Body Positron Emission TomographyThorsten Derlin, Rudolf A Werner, Desiree Weiberg, et al.
The Prostate|October 11, 2021
Pretherapeutic estimated glomerular filtration rate predicts development of chronic kidney disease in patients receiving PSMA-targeted radioligand therapyLiam Widjaja, Thorsten Derlin, Tobias L Ross, et al.
Pageof 36